Skip to content

About IPI

Our mission is to advance protein science to accelerate research and improve human health.

Unlocking protein biology

The Institute for Protein Innovation is pioneering a new approach to scientific discovery and collaboration. As a nonprofit research institute, we provide the biomedical research community with synthetic antibodies and deep protein expertise, empowering scientists to explore fundamental biological processes and pinpoint new targets for therapeutic development.

Two scientists in lab coats laughing.

Our research

IPI’s Receptor Engineering group tackles hard-to-reach antibodies to provide critical protein tools for research and therapeutic development.

More about our research

A man and a woman in front of a computer

Our people

We invest in people with the expertise and creativity to approach fundamental scientific questions from whole new angles.

Meet our team

How we're different

At IPI’s core is a platform that pairs state-of-the-art technology with skilled scientists from top institutions worldwide.

Our antibody production pipeline makes use of yeast display technology to produce high-quality synthetic recombinant antibodies, which go beyond the limitations of traditional antibodies.

These reagents, which drastically reduce cross-reactivity in downstream research, are critical to building knowledge of the human proteome and developing life-saving therapeutics.

Man working in cell biology lab.

Building an institute

  • 2015

    Tim Springer hatches the idea of IPI, hosting the first Board meeting in his home.

  • 2016

    IPI hires its first employee.

  • 2017

    With its yeast display library completed, IPI officially launches.

  • 2018

    IPI relocates to the Harvard Medical School campus.

  • 2019

    IPI hires Alex Burgin as its first executive director.

  • 2020

    IPI licenses its first antibody and launches its antibody validation campaign.

  • 2021

    IPI elects Samantha Singer as new Board chair and appoints Rob Meijers as interim executive director.

  • 2022

    IPI appoints Kenneth Fasman as president and CEO.

  • 2023

    IPI hosts its first symposium, IPI Surfacing. 

  • 2023

    IPI announces its partnership with Addgene.

Get in touch today

Back To Top